Michael E. Farkouh
Cardiovascular Clinical Research Center
New York University School of Medicine
530 First Avenue
New York
USA
Name/email consistency: high
- Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Farkouh, M.E., Kirshner, H., Harrington, R.A., Ruland, S., Verheugt, F.W., Schnitzer, T.J., Burmester, G.R., Mysler, E., Hochberg, M.C., Doherty, M., Ehrsam, E., Gitton, X., Krammer, G., Mellein, B., Gimona, A., Matchaba, P., Hawkey, C.J., Chesebro, J.H. Lancet (2004)









